Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111767034 | 11176703 | 4 | F | 20160902 | 20150610 | 20160916 | EXP | IN-AUROBINDO-AUR-APL-2015-04947 | AUROBINDO | 74.00 | YR | M | Y | 0.00000 | 20160916 | OT | CL | CL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111767034 | 11176703 | 1 | PS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | 1000 MG, EVERY 12 H | U | 77095 | 1000 | MG | |||||||
| 111767034 | 11176703 | 2 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | 1 DF, EVERY 12 H | U | 77095 | 1 | DF | |||||||
| 111767034 | 11176703 | 3 | SS | METFORMIN HYDROCHLORIDE W/VILDAGLIPTIN | METFORMIN HYDROCHLORIDEVILDAGLIPTIN | 1 | 50+1000 MG, EVERY 12 H | U | 0 | ||||||||||
| 111767034 | 11176703 | 4 | I | BISOPROLOL | BISOPROLOL | 1 | U | 0 | 1.25 | MG | |||||||||
| 111767034 | 11176703 | 5 | C | FUROSEMIDE /00032602/ | FUROSEMIDE | 1 | Unknown | 20 MG, EVERY 12 HOURS | U | 0 | 20 | MG | |||||||
| 111767034 | 11176703 | 6 | I | ACETYLSALICYLIC ACID | ASPIRIN | 1 | U | 0 | 100 | MG | |||||||||
| 111767034 | 11176703 | 7 | I | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | U | 0 | 25 | MG | |||||||||
| 111767034 | 11176703 | 8 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | 40 MG, DAILY | U | 0 | 40 | MG | |||||||
| 111767034 | 11176703 | 9 | C | ATORVASTATIN | ATORVASTATIN | 1 | U | 0 | 40 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111767034 | 11176703 | 1 | Diabetes mellitus |
| 111767034 | 11176703 | 3 | Diabetes mellitus |
| 111767034 | 11176703 | 4 | Product used for unknown indication |
| 111767034 | 11176703 | 5 | Cardiac disorder |
| 111767034 | 11176703 | 6 | Product used for unknown indication |
| 111767034 | 11176703 | 7 | Product used for unknown indication |
| 111767034 | 11176703 | 8 | Cardiac disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 111767034 | 11176703 | LT |
| 111767034 | 11176703 | HO |
| 111767034 | 11176703 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111767034 | 11176703 | Abdominal pain | |
| 111767034 | 11176703 | Agitation | |
| 111767034 | 11176703 | Atrioventricular block | |
| 111767034 | 11176703 | Blood creatine increased | |
| 111767034 | 11176703 | Blood urea increased | |
| 111767034 | 11176703 | Bradyarrhythmia | |
| 111767034 | 11176703 | Brain natriuretic peptide increased | |
| 111767034 | 11176703 | Diarrhoea | |
| 111767034 | 11176703 | Disorientation | |
| 111767034 | 11176703 | Drug interaction | |
| 111767034 | 11176703 | Electrocardiogram QRS complex prolonged | |
| 111767034 | 11176703 | Electrocardiogram QT prolonged | |
| 111767034 | 11176703 | Hyperkalaemia | |
| 111767034 | 11176703 | Hypoglycaemia | |
| 111767034 | 11176703 | Hypoperfusion | |
| 111767034 | 11176703 | Lactic acidosis | |
| 111767034 | 11176703 | Loss of consciousness | |
| 111767034 | 11176703 | Nausea | |
| 111767034 | 11176703 | Overdose | |
| 111767034 | 11176703 | Polyuria | |
| 111767034 | 11176703 | Presyncope | |
| 111767034 | 11176703 | Sinus bradycardia | |
| 111767034 | 11176703 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |